-
1
-
-
84875320909
-
Pediatric non alcoholic fatty liver disease: Old and new concept on development, progression, metabolic insight and potential treatment target
-
Giorgio V, Pruno E, Graziano F, Nobili V: Pediatric non alcoholic fatty liver disease: old and new concept on development, progression, metabolic insight and potential treatment target. BMC Pediatr 2013, 13:40.
-
(2013)
BMC Pediatr
, vol.13
, pp. 40
-
-
Giorgio, V.1
Pruno, E.2
Graziano, F.3
Nobili, V.4
-
2
-
-
79961058891
-
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk
-
Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C: Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol 2011, 17:3082–3091.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 3082-3091
-
-
Pacifico, L.1
Nobili, V.2
Anania, C.3
Verdecchia, P.4
Chiesa, C.5
-
3
-
-
77957375969
-
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease
-
Targher G, Day CP, Bonora E: Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Eng J Med 2011, 363:1341–1350.
-
(2011)
N Eng J Med
, vol.363
, pp. 1341-1350
-
-
Targher, G.1
Day, C.P.2
Bonora, E.3
-
4
-
-
79959453955
-
Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease
-
Alkhouri N, Carter-Kent C, Elias M, Feldstein AE: Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease. Clin Lipidiol 2011, 6:305–314.
-
(2011)
Clin Lipidiol
, vol.6
, pp. 305-314
-
-
Alkhouri, N.1
Carter-Kent, C.2
Elias, M.3
Feldstein, A.E.4
-
5
-
-
34347351228
-
Abdominal, visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study
-
Fox CS, Massaro JM, Hoffmann U, Pou K, Maurovich-Horvath O, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D’Agostino RB, O’Donnell CJ: Abdominal, visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39–48.
-
(2007)
Circulation
, vol.116
, pp. 39-48
-
-
Fox, C.S.1
Massaro, J.M.2
Hoffmann, U.3
Pou, K.4
Maurovich-Horvath, O.5
Liu, C.Y.6
Vasan, R.S.7
Murabito, J.M.8
Meigs, J.B.9
Cupples, L.A.10
D’Agostino, R.B.11
O’Donnell, C.J.12
-
6
-
-
77952680758
-
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham Heart Study
-
Speliotes F, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhorn JN, O’Donnell CJ, Fox CS: Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010, 51:1979–1987.
-
(2010)
Hepatology
, vol.51
, pp. 1979-1987
-
-
Speliotes, F.1
Massaro, J.M.2
Hoffmann, U.3
Vasan, R.S.4
Meigs, J.B.5
Sahani, D.V.6
Hirschhorn, J.N.7
O’Donnell, C.J.8
Fox, C.S.9
-
7
-
-
84887625928
-
Ectopic fat and cardiometabolic and vascular risk
-
Lim S, Meighs JB: Ectopic fat and cardiometabolic and vascular risk. Int J Cardiol 2013, 169:166–176.
-
(2013)
Int J Cardiol
, vol.169
, pp. 166-176
-
-
Lim, S.1
Meighs, J.B.2
-
9
-
-
76749098030
-
Serum chemerin and vaspin in non-alcoholic fatty liver disease
-
Kukla M, Zwirska-Korczala K, Hartleb M, Waluga M, Chwist A, Kajor M, Ciupinska-Kajor M, Berdowska A, Wozniak-Grygiel E, Buldak R: Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol 2010, 45:235–242.
-
(2010)
Scand J Gastroenterol
, vol.45
, pp. 235-242
-
-
Kukla, M.1
Zwirska-Korczala, K.2
Hartleb, M.3
Waluga, M.4
Chwist, A.5
Kajor, M.6
Ciupinska-Kajor, M.7
Berdowska, A.8
Wozniak-Grygiel, E.9
Buldak, R.10
-
10
-
-
78651368690
-
Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease
-
Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Eren F, Ozdagan O, Celikel CA, Imeryuz N, Kalayci C, Avsar E: Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scan J Gastroenterol 2011, 46:91–97.
-
(2011)
Scan J Gastroenterol
, vol.46
, pp. 91-97
-
-
Yilmaz, Y.1
Yonal, O.2
Kurt, R.3
Alahdab, Y.O.4
Eren, F.5
Ozdagan, O.6
Celikel, C.A.7
Imeryuz, N.8
Kalayci, C.9
Avsar, E.10
-
11
-
-
79952988824
-
Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease
-
Aktas B, Yilmaz Y, Eren F, Yonal O, Kurt R, Alahdab YO, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E: Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. Metabol Clin Experimental 2011, 60:544–549.
-
(2011)
Metabol Clin Experimental
, vol.60
, pp. 544-549
-
-
Aktas, B.1
Yilmaz, Y.2
Eren, F.3
Yonal, O.4
Kurt, R.5
Alahdab, Y.O.6
Celikel, C.A.7
Ozdogan, O.8
Imeryuz, N.9
Kalayci, C.10
Avsar, E.11
-
12
-
-
79960212414
-
Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease
-
Yilmaz Y, Kurt R, Gurdal A, Alahdab YO, Yonal D, Senates E, Polat N, Eren F, Imeryuz N, Oflan H: Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 2011, 217:125–129.
-
(2011)
Atherosclerosis
, vol.217
, pp. 125-129
-
-
Yilmaz, Y.1
Kurt, R.2
Gurdal, A.3
Alahdab, Y.O.4
Yonal, D.5
Senates, E.6
Polat, N.7
Eren, F.8
Imeryuz, N.9
Oflan, H.10
-
13
-
-
84907638181
-
Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease
-
Lebensztejn DM, Białokoz-Kalinowska I, Kłusek-Oksiuta M, Tarasow E, Wojtkowska M, Kaczmarski M: Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease. Adv Med Sci 2014, 59:81–84.
-
(2014)
Adv Med Sci
, vol.59
, pp. 81-84
-
-
Lebensztejn, D.M.1
Białokoz-Kalinowska, I.2
Kłusek-Oksiuta, M.3
Tarasow, E.4
Wojtkowska, M.5
Kaczmarski, M.6
-
14
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man
-
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985, 28:412–419.
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
Naylor, B.A.4
Treacher, D.F.5
Turner, R.C.6
-
15
-
-
0022645750
-
Ultrasound Canning in the detection of hepatic fibrosis and steatosis
-
Saverymuttu SH, Joseph AE, Maxwell JD: Ultrasound Canning in the detection of hepatic fibrosis and steatosis. Br Med J 1986, 292:13–15.
-
(1986)
Br Med J
, vol.292
, pp. 13-15
-
-
Saverymuttu, S.H.1
Joseph, A.E.2
Maxwell, J.D.3
-
16
-
-
17544385213
-
MR proton spectroscopy in liver examination of healthy individuals in vivo
-
Tarasów E, Siergiejczyk L, Panasiuk A, Kubas B, Dzienis W, Prokopowicz D, Walecki J: MR proton spectroscopy in liver examination of healthy individuals in vivo. Med Sci Monit 2002, 8:36–40.
-
(2002)
Med Sci Monit
, vol.8
, pp. 36-40
-
-
Tarasów, E.1
Siergiejczyk, L.2
Panasiuk, A.3
Kubas, B.4
Dzienis, W.5
Prokopowicz, D.6
Walecki, J.7
-
17
-
-
0030639658
-
Sampling variability of nonparametric estimates of the areas under receiver operating characteristic curves: An update
-
Hanley JA, Hajian-Tilaki KO: Sampling variability of nonparametric estimates of the areas under receiver operating characteristic curves: an update. Acad Radiol 1997, 4:49–58.
-
(1997)
Acad Radiol
, vol.4
, pp. 49-58
-
-
Hanley, J.A.1
Hajian-Tilaki, K.O.2
-
18
-
-
77954471976
-
Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery
-
Sell H, Divoux A, Poitou C, Basdevanta A, Bouillot JL, Bedossa P, Tordjman J, Eckel J, Clement K: Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2010, 95:2892:6.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, Issue.2892
, pp. 6
-
-
Sell, H.1
Divoux, A.2
Poitou, C.3
Basdevanta, A.4
Bouillot, J.L.5
Bedossa, P.6
Tordjman, J.7
Eckel, J.8
Clement, K.9
-
19
-
-
78651368690
-
Serum levels of omentin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease
-
Yilmaz Y, Yonal O, Kurt R, Alahdab YO, Eren F, Ozdogan O, Celikel CA, Imeryuz N, Kalayci C, Avsar E: Serum levels of omentin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol 2011, 46:91–97.
-
(2011)
Scand J Gastroenterol
, vol.46
, pp. 91-97
-
-
Yilmaz, Y.1
Yonal, O.2
Kurt, R.3
Alahdab, Y.O.4
Eren, F.5
Ozdogan, O.6
Celikel, C.A.7
Imeryuz, N.8
Kalayci, C.9
Avsar, E.10
-
20
-
-
80054088904
-
Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis
-
Genc H, Dogru T, Tapan S, Kara M, Ercin CN, Aslan F, Kantarcioglu M, Karslioglu Y, Sertoglu E, Erbil MK, Bagci S: Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis. Scand J Gastroenterol 2011, 46:1355–1361.
-
(2011)
Scand J Gastroenterol
, vol.46
, pp. 1355-1361
-
-
Genc, H.1
Dogru, T.2
Tapan, S.3
Kara, M.4
Ercin, C.N.5
Aslan, F.6
Kantarcioglu, M.7
Karslioglu, Y.8
Sertoglu, E.9
Erbil, M.K.10
Bagci, S.11
-
21
-
-
84896055674
-
Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease
-
Ye Z, Wang S, Yang Z, He M, Zhang S, Zhang W, Wen J, Li Q, Huang Y, Wang X, Lu B, Zhang Z, Su Q, Hu R: Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease. Mol Biol Rep 2014, 41:1317–1323.
-
(2014)
Mol Biol Rep
, vol.41
, pp. 1317-1323
-
-
Ye, Z.1
Wang, S.2
Yang, Z.3
He, M.4
Zhang, S.5
Zhang, W.6
Wen, J.7
Li, Q.8
Huang, Y.9
Wang, X.10
Lu, B.11
Zhang, Z.12
Su, Q.13
Hu, R.14
-
22
-
-
84863993937
-
Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients
-
Chen H-Y, Lin C-C, Chiu Y-L, Hsu SP, Pai MF, Yang JY, Peng YS: Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients. PlosONE 2012, 7:e38415.
-
(2012)
PlosONE
, vol.7
, pp. e38415
-
-
Chen, H.-Y.1
Lin, C.-C.2
Chiu, Y.-L.3
Hsu, S.P.4
Pai, M.F.5
Yang, J.Y.6
Peng, Y.S.7
-
23
-
-
59649111378
-
MRI in identifying hepatic steatosis in obese children and relations to ultrasonography and metabolic findings
-
Pozzato C, Radelli G, Dall’Asta C, Veduci E, Villa A, Villa C, Scaglioni S, Riva E, Pontiroli AE, Cornalba G, Giovannini M: MRI in identifying hepatic steatosis in obese children and relations to ultrasonography and metabolic findings. J Pediatr Gastroenterol Nutr 2008, 47:493–499.
-
(2008)
J Pediatr Gastroenterol Nutr
, vol.47
, pp. 493-499
-
-
Pozzato, C.1
Radelli, G.2
Dall’Asta, C.3
Veduci, E.4
Villa, A.5
Villa, C.6
Scaglioni, S.7
Riva, E.8
Pontiroli, A.E.9
Cornalba, G.10
Giovannini, M.11
-
24
-
-
68049120181
-
Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography, and magnetic resonance
-
Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F: Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography, and magnetic resonance. J Hepatol 2009, 51:433–445.
-
(2009)
J Hepatol
, vol.51
, pp. 433-445
-
-
Schwenzer, N.F.1
Springer, F.2
Schraml, C.3
Stefan, N.4
Machann, J.5
Schick, F.6
-
25
-
-
84859970076
-
Diagnosis of nonalcoholic fatty liver disease in children and adolescents: Position paper of the ESPGHAN Hepatology Committee
-
Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, Durmaz O, Lacaille F, McLin V, Nobili V: Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 2012, 54:700–713.
-
(2012)
J Pediatr Gastroenterol Nutr
, vol.54
, pp. 700-713
-
-
Vajro, P.1
Lenta, S.2
Socha, P.3
Dhawan, A.4
McKiernan, P.5
Baumann, U.6
Durmaz, O.7
Lacaille, F.8
McLin, V.9
Nobili, V.10
-
26
-
-
34247643846
-
Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem?
-
Roberts EA: Pediatric nonalcoholic fatty liver disease (NAFLD): a “growing” problem? J Hepatol 2007, 46:1133–1142.
-
(2007)
J Hepatol
, vol.46
, pp. 1133-1142
-
-
Roberts, E.A.1
-
27
-
-
84876749355
-
Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis
-
Deng Y, Wang H, Lu Y, Zhang Q, Huang J, Zhu R, Yang J, Zhang R, Zhang D, Shen W, Wing G, Yang Y: Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis. Endocrinology 2013, 154:1794–1801.
-
(2013)
Endocrinology
, vol.154
, pp. 1794-1801
-
-
Deng, Y.1
Wang, H.2
Lu, Y.3
Zhang, Q.4
Huang, J.5
Zhu, R.6
Yang, J.7
Zhang, R.8
Zhang, D.9
Shen, W.10
Wing, G.11
Yang, Y.12
-
28
-
-
84882741140
-
Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver
-
Krautbauer S, Wanninger J, Eisinger K, Hader Y, Beck M, Kopp A, Schmid A, Weiss TS, Dorn C, Buechler C: Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Exp Mol Pathol 2013, 95:199–205.
-
(2013)
Exp Mol Pathol
, vol.95
, pp. 199-205
-
-
Krautbauer, S.1
Wanninger, J.2
Eisinger, K.3
Hader, Y.4
Beck, M.5
Kopp, A.6
Schmid, A.7
Weiss, T.S.8
Dorn, C.9
Buechler, C.10
-
29
-
-
84885159392
-
Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease
-
Docke S, Lock JF, Birkenfeld AL, Koppe S, Lieske S, Rieger A, Raschzok N, Sauer IM, Florian S, Osterhoff MA, Heller R, Herrmann K, Lindenmuller S, Horn P, Bauer M, Weickert MO, Neuhaus P, Stockmann M, Mohlig M, Pfeiffer AF, von Loeffelholz C: Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. Eur J Endocrinol 2013, 169:547–557.
-
(2013)
Eur J Endocrinol
, vol.169
, pp. 547-557
-
-
Docke, S.1
Lock, J.F.2
Birkenfeld, A.L.3
Koppe, S.4
Lieske, S.5
Rieger, A.6
Raschzok, N.7
Sauer, I.M.8
Florian, S.9
Osterhoff, M.A.10
Heller, R.11
Herrmann, K.12
Lindenmuller, S.13
Horn, P.14
Bauer, M.15
Weickert, M.O.16
Neuhaus, P.17
Stockmann, M.18
Mohlig, M.19
Pfeiffer, A.F.20
Von Loeffelholz, C.21
more..
-
30
-
-
84866071750
-
Systemic inflammation in childhood obesity: Circulating inflammatory mediators and activated CD 14++ monocytes
-
Schipper HS, Nuboer R, Prop S, van den HAM HJ, de Boer FK, Kesmir C, Mombers IM, van Bekkum KA, Woudstra J, Kiefl JH, Hoefer IE, de Jager W, Prakken B, van Summeren M, Kalkhoven E: Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD 14++ monocytes. Diabetologia 2012, 55:2800–2810.
-
(2012)
Diabetologia
, vol.55
, pp. 2800-2810
-
-
Schipper, H.S.1
Nuboer, R.2
Prop, S.3
Van Den Ham, H.J.4
De Boer, F.K.5
Kesmir, C.6
Mombers, I.M.7
Van Bekkum, K.A.8
Woudstra, J.9
Kiefl, J.H.10
Hoefer, I.E.11
De Jager, W.12
Prakken, B.13
Van Summeren, M.14
Kalkhoven, E.15
-
31
-
-
84859538216
-
Chemerin as a mediator between obesity and vascular inflammation in children
-
Landgraf K, Friebe D, Ulrich T, Kratzsch J, Dittrich K, Herberth G, Adams V, Kiess W, Erbs S, Korner A: Chemerin as a mediator between obesity and vascular inflammation in children. J Clin Endocrinol Metab 2012, 97:556–564.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 556-564
-
-
Landgraf, K.1
Friebe, D.2
Ulrich, T.3
Kratzsch, J.4
Dittrich, K.5
Herberth, G.6
Adams, V.7
Kiess, W.8
Erbs, S.9
Korner, A.10
|